Gene · 23327
Papers2,568
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,568
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
LncRNA AGAP2 antisense RNA 1 stabilized by insulin-like growth factor 2 mRNA binding protein 3 promotes macrophage M2 polarization in clear cell renal cell carcinoma through regulation of the microRNA-9-5p/THBS2/PI3K-Akt pathway. | Cancer Cell Int | 2023 | 38110984 | PubTator, text mining | PubMed |
| The involvement of E3 ubiquitin ligases in the development and progression of colorectal cancer. | Cell Death Discov | 2023 | 38104139 | PubTator, text mining | PubMed |
| Structural Dynamics of E6AP E3 Ligase HECT Domain and Involvement of a Flexible Hinge Loop in the Ubiquitin Chain Synthesis Mechanism. | Nano Lett | 2023 | 38055898 | PubTator, text mining | PubMed |
| Insights into the ISG15 transfer cascade by the UBE1L activating enzyme. | Nat Commun | 2023 | 38042859 | PubTator, text mining | PubMed |
| NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor. | Front Pharmacol | 2023 | 38027016 | PubTator, text mining | PubMed |
| Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy. | Front Immunol | 2023 | 38022518 | PubTator, text mining | PubMed |
| Liddle syndrome presenting with normal aldosterone levels: A case report. | Medicine (Baltimore) | 2023 | 38013303 | PubTator, text mining | PubMed |
| Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers. | Biomark Res | 2023 | 37981718 | PubTator, text mining | PubMed |
| Transforming Medical Paradigms: A Cutting-Edge Review of Genomic and Robotic Medical and Surgical Approaches in the Battle Against Diabetes, Hypertension, and Cardiovascular Issues. | Cureus | 2023 | 37965396 | PubTator, text mining | PubMed |
| CHOP upregulation and dysregulation of the mature form of the SNAT2 amino acid transporter in the placentas from small for gestational age newborns. | Cell Commun Signal | 2023 | 37957724 | PubTator, text mining | PubMed |
| Proceedings of the Eleventh International Meeting on Neuroacanthocytosis Syndromes. | Tremor Other Hyperkinet Mov (N Y) | 2023 | 37928888 | PubTator, text mining | PubMed |
| Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential. | Front Pharmacol | 2023 | 37920209 | PubTator, text mining | PubMed |
| A Proteomics-Based Approach Identifies the NEDD4 Adaptor NDFIP2 as an Important Regulator of Ifitm3 Levels. | Viruses | 2023 | 37896772 | PubTator, text mining | PubMed |
| Renal Organic Anion Transporters 1 and 3 In Vitro: Gone but Not Forgotten. | Int J Mol Sci | 2023 | 37895098 | PubTator, text mining | PubMed |
| The Impact of Neurotransmitters on the Neurobiology of Neurodegenerative Diseases. | Int J Mol Sci | 2023 | 37895020 | PubTator, text mining | PubMed |
| L-Type Amino Acid Transporter 1 (LAT1) Promotes PMA-Induced Cell Migration through mTORC2 Activation at the Lysosome. | Cells | 2023 | 37887348 | PubTator, text mining | PubMed |
| FOXA2 Suppression by TRIM36 Exerts Anti-Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4-Regulated Ferroptosis. | Adv Sci (Weinh) | 2023 | 37875418 | PubTator, text mining | PubMed |
| An siRNA library screen identifies CYLD and USP34 as deubiquitinases that regulate GPCR-p38 MAPK signaling and distinct inflammatory responses. | J Biol Chem | 2023 | 37865315 | PubTator, text mining | PubMed |
| Primate-specific isoform of Nedd4-1 regulates substrate binding via Ser/Thr phosphorylation and 14-3-3 binding. | Sci Rep | 2023 | 37863970 | PubTator, text mining | PubMed |
| CRISPR-Cas9 delivery strategies with engineered extracellular vesicles. | Mol Ther Nucleic Acids | 2023 | 37842166 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23327/papers?page=12